Steris Signs $2.1B M&A Deal with Xodus Medical, Inc.
STERIS plc, through its subsidiary, has entered into a definitive agreement to acquire Xodus Medical, Inc., a specialty surgical products business, for $2.1 billion in cash. The deal includes potential additional earnout consideration of up to $150 million based on 2028 performance targets and is expected to close by December 31, 2026. STERIS has secured a $2.0 billion bridge financing commitment from JPMorgan and Goldman Sachs to support the acquisition.
- Value
- $2.1B
- Counterparty
- Xodus Medical, Inc.